These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 25430795)

  • 21. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic potential of cell-internalizing aptamers.
    Zhou J; Rossi JJ
    Curr Top Med Chem; 2009; 9(12):1144-57. PubMed ID: 19860714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A basic insight into aptamer-drug conjugates (ApDCs).
    Xuan W; Peng Y; Deng Z; Peng T; Kuai H; Li Y; He J; Jin C; Liu Y; Wang R; Tan W
    Biomaterials; 2018 Nov; 182():216-226. PubMed ID: 30138784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aptamers used for biosensors and targeted therapy.
    Ning Y; Hu J; Lu F
    Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy.
    Jurek PM; Zabłocki K; Waśko U; Mazurek MP; Otlewski J; Jeleń F
    Int J Nanomedicine; 2017; 12():2941-2950. PubMed ID: 28442904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aptamer-Functionalized Hybrid Nanostructures for Sensing, Drug Delivery, Catalysis and Mechanical Applications.
    Vázquez-González M; Willner I
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleic acid aptamers: an emerging frontier in cancer therapy.
    Zhu G; Ye M; Donovan MJ; Song E; Zhao Z; Tan W
    Chem Commun (Camb); 2012 Nov; 48(85):10472-80. PubMed ID: 22951893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aptamers: multifunctional molecules for biomedical research.
    Banerjee J; Nilsen-Hamilton M
    J Mol Med (Berl); 2013 Dec; 91(12):1333-42. PubMed ID: 24045702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleic acids delivering nucleic acids.
    Catuogno S; Esposito CL; Condorelli G; de Franciscis V
    Adv Drug Deliv Rev; 2018 Sep; 134():79-93. PubMed ID: 29630917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications.
    Ni S; Zhuo Z; Pan Y; Yu Y; Li F; Liu J; Wang L; Wu X; Li D; Wan Y; Zhang L; Yang Z; Zhang BT; Lu A; Zhang G
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9500-9519. PubMed ID: 32603135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in Micro/Nanomaterial-Based Aptamer Selection Strategies.
    Kim DM; Go MJ; Lee J; Na D; Yoo SM
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomedical Applications of DNA-Conjugated Gold Nanoparticles.
    Wang CC; Wu SM; Li HW; Chang HT
    Chembiochem; 2016 Jun; 17(12):1052-62. PubMed ID: 26864481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aptamer-conjugated nanomaterials for bioanalysis and biotechnology applications.
    Chen T; Shukoor MI; Chen Y; Yuan Q; Zhu Z; Zhao Z; Gulbakan B; Tan W
    Nanoscale; 2011 Feb; 3(2):546-56. PubMed ID: 21109879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of pathogenic bacteria via nanomaterials-modified aptasensors.
    Sharifi S; Vahed SZ; Ahmadian E; Dizaj SM; Eftekhari A; Khalilov R; Ahmadi M; Hamidi-Asl E; Labib M
    Biosens Bioelectron; 2020 Feb; 150():111933. PubMed ID: 31818764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aptamers in neuro-oncology: An emerging therapeutic modality.
    Doherty C; Wilbanks B; Khatua S; Maher LJ
    Neuro Oncol; 2024 Jan; 26(1):38-54. PubMed ID: 37619244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.